Establishment Labs (NASDAQ:ESTA) Announces Quarterly Earnings Results, Misses Estimates By $0.34 EPS

Establishment Labs (NASDAQ:ESTA) released its quarterly earnings data on Wednesday. The company reported ($0.98) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.34), Zacks reports. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%.

Establishment Labs Price Performance

Shares of NASDAQ:ESTA traded up $0.28 during trading on Wednesday, reaching $36.06. 614,546 shares of the company traded hands, compared to its average volume of 653,722. Establishment Labs has a 52 week low of $28.16 and a 52 week high of $60.12. The firm has a market capitalization of $1.01 billion, a PE ratio of -13.98 and a beta of 1.12. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The company’s 50 day moving average is $37.50 and its two-hundred day moving average is $41.37.

Analyst Upgrades and Downgrades

Separately, Stephens upgraded shares of Establishment Labs to a “strong-buy” rating in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $60.60.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.